Wulandari Harahap, P., S. Putra Tarigan, and N. Novisari Soeroso. “Adverse Event Of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment In Medan Among Pulmonary Adenocarcinoma: Focus On Non-Hematologic Toxicity”. International Journal of Health and Pharmaceutical (IJHP), vol. 5, no. 3, Aug. 2025, pp. 422-9, doi:10.51601/ijhp.v5i3.429.